[Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use*; D002908:Chronic Disease; D002994:Clofibrate / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D011727:Pyridinolcarbamate / Q000627:therapeutic use*
D002219:Carbamates; D004338:Drug Combinations; D011727:Pyridinolcarbamate; D002994:Clofibrate
Terapia delle arteriopatie obliteranti croniche periferiche (A.O.C.P.) arteriosclerotiche degli arti inferiori con una nuova associazione farmacologica